Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Bcl11b: A Master Transcription Factor Controlling Human NK Cell Development
Cichocki, F. M., Eaton, A., Felices, M. & Wang, J.
NIH NAT'L HEART, LUNG, AND BLOOD INSTITU
7/1/21 → 4/30/26
Project: Research project
-
TriKE, Biology, Optimization, Improved Administration, and GMP Manufacturing Support
6/16/21 → 6/30/23
Project: Research project
-
Developing Next-Generation Cryopreservation Media for Natural Killer Cell Therapies
5/1/21 → 4/30/23
Project: Research project
-
Leveraging low oxygen environments for improved Natural Killer cell immunotherapy
Kennedy, P., Felices, M., Lou, E., Luo, X. & Miller, J. S.
5/1/21 → 10/31/23
Project: Research project
-
NK cells, their receptors, and cancer therapy
Miller, J. S., Bachanova, V., Basu, S., Brunstein, C. G., Cichocki, F. M., Felices, M., Geller, M. A., Grzywacz, B. J., Le, C. T., Luo, X., Starr, T., Walcheck, B., Warlick, E. D. & Weisdorf, D. J.
NIH NATIONAL CANCER INSTITUTE (NCI)
4/9/21 → 3/31/26
Project: Research project
-
Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer
Kennedy, P., Felices, M. & Miller, J. S., Dec 2022, In: Stem Cell Research and Therapy. 13, 1, 165.Research output: Contribution to journal › Review article › peer-review
Open Access -
Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation
Yang, J., Liao, Q., Price, M. A., Moriarity, B., Wolf, N., Felices, M., Miller, J. S., Geller, M. A., Bendzick, L. E., Hopps, R., Starr, T. K., O'Connor, C. H., Tarullo, S., Nelson, A. C., Turley, E., Wang, J. & Mc Carthy, J. B., Feb 2022, In: Translational Oncology. 16, 101318.Research output: Contribution to journal › Article › peer-review
Open Access -
Activation of ADAM17 by IL-15 Limits Human NK Cell Proliferation
Mishra, H. K., Dixon, K., Pore, N., Felices, M., Miller, J. S. & Walcheck, B., Jul 22 2021, In: Frontiers in immunology. 12, 711621.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
A HER2 tri-specific NK cell engager mediates efficient targeting of human ovarian cancer
Vallera, D. A., Oh, F., Kodal, B., Hinderlie, P., Geller, M. A., Miller, J. S. & Felices, M., Aug 8 2021, In: Cancers. 13, 16, 3994.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C + NK cells to target myeloid leukemia.
Chiu, E., Felices, M., Cichocki, F., Davis, Z., Wang, H., Tuninga, K., Vallera, D. A., Lee, T., Bjordahl, R., Malmberg, K. J., Valamehr, B. & Miller, J. S., Dec 1 2021, In: Molecular Therapy. 29, 12, p. 3410-3421 12 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations